An analysis of clinical trials found the anti-smoking drug Chantix, manufactured by Pfizer Inc., produced a higher rate of heart attacks and strokes in patients who used the treatment compared to those who didn’t.
An FDA warning says it’s “more likely that (the increased risk) is related to the drug and not purely a chance finding.”
Of 4,190 Chantix users, Bloomberg reports, 13 were found to have experienced a major cardiovascular event ...
continue reading...
